CLINICAL AND PATHOGENETIC ASPECTS OF HEART DAMAGE IN SYSTEMIC CONNECTIVE TISSUE DISEASES

Authors

  • Sadikova Raykhon Rakhimbekovna Assistant Professor, Department of Propaedeutics of Childhood Diseases No. 2, TSMU, Tashkent State Medical University Author

Keywords:

Systemic connective tissue diseases, cardiac involvement, autoimmune inflammation, myocarditis, pericarditis, accelerated atherosclerosis, immunosuppressive therapy.

Abstract

Systemic connective tissue diseases (SCTDs) represent a heterogeneous group of chronic, often progressive, autoimmune disorders characterized by the involvement of collagen and elastin-containing tissues. Among the most common SCTDs are systemic lupus erythematosus, systemic sclerosis, polymyositis, dermatomyositis, Sjögren's syndrome, and rheumatoid arthritis. These conditions can affect almost any organ system, but one of their most significant and life-threatening complications is cardiac involvement. Understanding the clinical and pathogenetic aspects of heart damage in the context of systemic connective tissue diseases is essential for improving prognosis, management strategies, and patient survival.

Downloads

Published

2026-04-27

Issue

Section

Articles

How to Cite

CLINICAL AND PATHOGENETIC ASPECTS OF HEART DAMAGE IN SYSTEMIC CONNECTIVE TISSUE DISEASES. (2026). Educator Insights: Journal of Teaching Theory and Practice, 2(4), 307-313. https://brightmindpublishing.com/index.php/EI/article/view/2489